LAX.SH
INSECTICIDES (I) LTD·AGROCHEMICAL 33.44PESTICIDES 39.23·Fertilizers & Agrochemicals Companies
Price
609.75
+0.52%52W Range
Market Cap
₹1,774.24 Cr
Traded: ₹1.27 Cr (0.07%) 0.0x
Free Float: ₹229.23 Cr (0.56% of FF traded)
Volume · 60D trend
20.97 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| ROE | +13.0% | +11.0% | +12.0% | -- | -- | Stable |
| Return | +7.0% | +5.0% | +11.0% | -35.0% | -- | Stable |
| Profit | +13.0% | +6.0% | +30.0% | -- | -17.0% | Stable |
| Sales | +9.0% | +9.0% | +6.0% | -- | +1.0% | Decelerating |
Quarterly Results
Dec 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023PDF ↗ | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 612 | 426 | 385 | 638 | 691 | 359 | 358 | 627 | 657 | 272 | 358 | 696 | 640 | 302 | 357 |
| Expenses | 544 | 401 | 358 | 548 | 607 | 330 | 327 | 538 | 585 | 264 | 332 | 614 | 594 | 331 | 333 |
| Operating Profit | 68 | 25 | 27 | 89 | 85 | 28 | 31 | 90 | 72 | 9 | 26 | 82 | 46 | -29 | 23 |
| OPM % | 11.0% | 6.0% | 7.0% | 14.0% | 12.0% | 8.0% | 9.0% | 14.0% | 11.0% | 3.3% | 7.0% | 12.0% | 7.0% | -9.0% | 7.0% |
| Other Income | 6 | 5 | 1 | 3 | 4 | 3 | 0 | 2 | 3 | 5 | 1 | 0 | 4 | 0 | 0 |
| Interest | 5 | 4 | 5 | 4 | 4 | 2 | 1 | 2 | 2 | 2 | 3 | 3 | 3 | 4 | 5 |
| Depreciation | 10 | 9 | 9 | 9 | 7 | 7 | 8 | 7 | 7 | 8 | 7 | 7 | 7 | 7 | 6 |
| Profit Before Tax | 59 | 16 | 14 | 79 | 77 | 22 | 22 | 82 | 66 | 4 | 17 | 72 | 40 | -39 | 12 |
| Tax % | 25.0% | 27.0% | 27.0% | 25.0% | 25.0% | 37.0% | 22.0% | 25.0% | 25.0% | -106.0% | 28.0% | 26.0% | 26.0% | -25.0% | 25.0% |
| Net Profit | 44 | 12 | 10 | 59 | 58 | 14 | 17 | 61 | 49 | 8 | 12 | 53 | 29 | -29 | 9 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 15.1 | 4.0 | 3.6 | 20.3 | 20.0 | 4.8 | 6.0 | 21.1 | 16.7 | 2.6 | 4.2 | 18.0 | 9.8 | -9.9 | 3.2 |
| Sales Growth (YoY) | -11.4% | 18.7% | 7.5% | 1.8% | 5.2% | 32.0% | 0.0% | -9.9% | 2.7% | -9.9% | 0.3% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 43.7% | 10.7% | -39.7% | -7.7% | 92.5% | 0.3% | -42.9% | -4.6% | 141.5% | -24.0% | -48.6% | 8.8% | 111.9% | -15.4% | -- |
| OP Growth (YoY) | -20.0% | -10.7% | -12.9% | -1.1% | 18.1% | 211.1% | 19.2% | 9.8% | 56.5% | 131.0% | 13.0% | -- | -- | -- | -- |
| OP Growth (QoQ) | 172.0% | -7.4% | -69.7% | 4.7% | 203.6% | -9.7% | -65.6% | 25.0% | 700.0% | -65.4% | -68.3% | 78.3% | 258.6% | -226.1% | -- |
| Profit Growth (YoY) | -- | -15.7% | -39.6% | -3.9% | 17.7% | 79.0% | 41.1% | 15.7% | 69.4% | 126.5% | 31.4% | 18.6% | -23.9% | -231.2% | 13.4% |
| EPS Growth (YoY) | -24.5% | -15.7% | -39.5% | -3.9% | 19.7% | 82.1% | 43.5% | 17.6% | 69.3% | 126.5% | 31.2% | -- | -- | -- | -- |
| EPS Growth (QoQ) | 275.1% | 11.4% | -82.2% | 1.7% | 318.7% | -20.1% | -71.8% | 26.7% | 536.6% | -37.0% | -76.8% | 82.3% | 199.5% | -412.3% | -- |
| OP Margin | 11.1% | 5.9% | 7.0% | 13.9% | 12.3% | 7.8% | 8.7% | 14.3% | 11.0% | 3.3% | 7.3% | 11.8% | 7.2% | -9.6% | 6.4% |
| Net Margin | 7.2% | 2.8% | 2.6% | 9.3% | 8.4% | 3.9% | 4.8% | 9.7% | 7.5% | 2.9% | 3.4% | 7.6% | 4.5% | -9.6% | 2.5% |
| Material Cost % | -- | 70.0% | 68.0% | 66.0% | 71.0% | 63.0% | 64.0% | 68.0% | 72.0% | 68.0% | 70.0% | 75.0% | 79.0% | 88.0% | 75.0% |
| Employee Cost % | -- | 9.0% | 9.0% | 7.0% | 6.0% | 8.0% | 9.0% | 6.0% | 6.0% | 9.0% | 8.0% | 5.0% | 5.0% | 7.0% | 6.0% |
| P/S | 0.86 | 0.88 | 1.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 14.17 | 13.56 | 14.69 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 1.45 | 1.55 | 1.73 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Earnings Call Transcript for quarter ended June 30, 2026
Pursuant to Regulation 44(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find the enclosed Voting Results of 29th ....
Pursuant to Regulation 44(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find the enclosed Voting Results of 29th ....
Outcome of 29TH AGM held today
Newspaper advertisement of Unaudited Financial Results for the First Quarter ended June 30, 2026.
Earnings Audio Call for quarter ended June 30, 2026
Enclosed is the Earning Presentation for the Quarter ended June 30, 2026.
Enclosed is the Press release for Quarter ended June 30, 2026.
Unaudited Standalone And Consolidated Results For the First Quarter Ended June 30, 2026
Enclosed is the Outcome of Board Meeting held today.
Intimation of Earning Conference Call for Q1 FY27
Insecticides (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve Intimation of Board Meeting ....
Newspaper Advertisement -Public Notice after dispatch of Notice of the 29th Annual General Meeting to be held on August 12, 2026.
Notice of the 29th Annual General Meeting of Insecticides (India) Limited
BRSR for FY 2026
Annual Report for FY 2026
Newspaper Advertisement -Public Notice before dispatch of Notice for the 29th Annual General Meeting ('AGM') and Annual Report for the financial year ended March 31, 2026.
Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
Closure of Trading Window
Newspaper advertisement-Second 100 days campaign named 'Saksham Niveshak'
Newspaper advertisement on Notice of transfer of equity shares of the Company to IEPF
Newspaper publication for Q4 & FY 26 Results.
Outcome of Board Meeting held today
Formulation of Employee Stock Purchase Scheme 2026
Results for Q4 & FY ended March 31, 2026
Appointment of Mr. Atul Kumar as a Vice President- Sales (North), a Senior Management Personnel (SMP)
Resignation of Mrs. Nikunj Aggarwal as Whole Time Director
Appointment of Mr. Sanskar Aggarwal as Whole Time Director (Additional)
Earning Press Release for Q4 & FY ended March 31, 2026
Appointment of Internal Auditor
Earning Presentation for Q4 & FY ended March 31, 2026
Annual Secretarial Compliance Report for FY ended March 31, 2026
Audio Recording of the Earning Conference Call for the Fourth Quarter and Financial Year ended March 31, 2026.
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Product Launch
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Product Launch
Intimation for resignation of Senior Management Personnel & Directorship in Subsidiary Company- Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations ....
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015.
Earning Call Intimation for Q4 & FY ended March 31, 2026
Insecticides (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve Intimation of Board Meeting ....
Intimation of Review of Credit Rating
Intimation under SEBI Listing Obligations and Disclosure Requirements), Regulations, 2015 ('SEBI Listing Regulations')- Newspaper advertisement "Saksham Niveshak"
Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, we wish to inform you that the Patent Office, Government of India has granted the ....
Closure of Trading Window
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015
The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(i)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
Earning call Transcript for quarter and nine month December 31, 2025.
Newspaper publication of Results for third quarter and nine months ended December 31, 2025
Declared Interim Dividend for FY 2025-2026
Declared Interim Dividend for FY 2025-2026
Annual Reports
16Credit Ratings
6Concalls
35Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025Jun 2025
30 Jun 2025Feb 2025
28 Feb 2025Nov 2024
30 Nov 2024Aug 2024
31 Aug 2024Jun 2024
30 Jun 2024May 2024
31 May 2024Feb 2024
29 Feb 2024Nov 2023
30 Nov 2023Aug 2023
31 Aug 2023Jun 2023
30 Jun 2023Feb 2023
28 Feb 2023Dec 2022
31 Dec 2022Nov 2022
30 Nov 2022Aug 2022
31 Aug 2022May 2022
31 May 2022Feb 2022
28 Feb 2022Nov 2021
30 Nov 2021Oct 2021
31 Oct 2021Aug 2021
31 Aug 2021Jun 2021
30 Jun 2021Feb 2021
28 Feb 2021Nov 2020
30 Nov 2020Aug 2020
31 Aug 2020Jun 2020
30 Jun 2020Feb 2020
29 Feb 2020Dec 2019
31 Dec 2019Nov 2019
30 Nov 2019Jul 2019
31 Jul 2019May 2019
31 May 2019Feb 2019
28 Feb 2019Nov 2018
30 Nov 2018Sep 2018
30 Sept 2018Held by Mutual Funds
2 schemes hold INSECTICID · sorted by weight